Particle.news
Download on the App Store
3 ARTICLES
·
last mo.

Court Freeze of U.S. Vaccine Panel Puts New Shots, Coverage in Limbo

The freeze leaves new and updated shots without clear federal guidance that insurers use to decide coverage.

Dr. Robert Malone listens to Aaron Siri during a meeting of the Advisory Committee on Immunization Practices (ACIP) to discuss recommendations for the childhood vaccine schedule at the Centers for Disease Control and Prevention in Atlanta, Georgia, U.S., December 5, 2025. REUTERS/Alyssa Pointer/File Photo
Image

Overview

  • A federal judge halted the CDC’s vaccine advisory panel after ruling most Robert F. Kennedy Jr. appointees were unqualified, putting their votes on hold.
  • The CDC now has no working body to set new recommendations, creating a gap for COVID updates and other routine vaccine advice.
  • Without ACIP guidance, newly licensed shots can be prescribed but may not be covered by insurers or included in federal programs.
  • AHIP pledged to cover vaccines that were on the ACIP list as of Sept. 1, 2025 through the end of 2026, giving plans a short-term path.
  • Several products await guidance, including RSV vaccines for adults 18 to 49 at higher risk, and pipeline shots like Moderna’s mRNA flu and Pfizer–Valneva’s Lyme vaccine could reach the market without federal recommendations.